Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
PBF Energy Inc PBF Q4 2025 earnings far exceed analyst estimates shares gain 403 percent today LENZ Therapeutics LENZ Stock Company Update 560 20260418 TOI The Oncology Institute Inc reports a narrower than projected Q4 2025 loss beating consensus EPS estimates by 34 percent Enterprise EFSC Stock Growth Opportunities Grinds Higher 20260418 Mobix Labs MOBX Competitive Advantages Mobix Labs Inc posts record revenue amid net loss headwinds Iris IRAB Stock Why It Matters Today Touches High 20260418 OR OR Road Ahead OR Royalties Inc posts 144 EPS miss vs Street estimates TROX Tronox Holdings plc Ordinary Shares UK posts widerthanexpected Q4 2025 loss as its shares drop 48 today What are the key catalysts for Pebblebrook PEB stock Mini Rally 20260418 Cognition CGTX Stock Extended Hours Technical Strength 20260416 Nexentis Technologies NXTS Stock Breaking Downtrend Soars 20260420 Is 3D Systems DDD stock considered stable In Focus 20260420 Alliance Res ARLP Stock Cancelled Order 070 20260420 Is SunPower SPWR stock losing technical support Bearish Momentum 20260420 Battalion Oil BATL Balance Sheet Review Q2 2023 Profit Surprises SSAC SPACSphere management highlights merger pipeline progress and key target verticals for its planned business combination Will SharonAI Holdings SHAZ stock fall further Q1 2026 Earnings Report CHR Cheer reports 11 percent Q1 2026 revenue growth shares dip 117 percent after quarterly earnings release Is EPR Properties EPR stock a buy today Stalls 20260420 SP Global Inc SPGI Upgrades SiriusPoint Ltd Core Insurance Subsidiaries to A on Proven Operational and Capital Strength ArtsWay ARTW Stock Piles Into ArtsWay ARTW Stock Smart Money Outflows 20260420 Is Arbe ARBE stock facing investor skepticism Arbe posts 2 EPS beat solid quarterly revenue SAY Saratoga notches 227 percent Q1 2026 EPS beat shares dip marginally following earnings release Who Backs Jyong Biotech MENS Stock Risk Aversion 20260420 Is HIVE HIVE stock attractive at current levels Steep loss delivers 423 negative EPS surprise vs consensus Biogen Inc BIIB Secures Felzartamab Rights to Challenge Darzalex Dominance in Chinas Multiple Myeloma Market USGOW US quarterly earnings metrics are not yet available with investors awaiting fresh operational updates What initial guidance ONE Gas OGS ONE Gas posts 14 EPS miss vs analyst estimates